Bright Minds - A Biotechnology Company in Canada

Since Bright Minds Biosciences has already initiated trading publicly on Canadian Stock Exchange (CSE), under the symbol of the drug trade, that company is serving as one of the most reliable investment options for psychedelic stocks .

In the present scenario, when mental illness has become one of the biggest challenges for the health sector, the Bright Minds Biosciences concept looks promising. The biotechnology start-up has a great team with decades of experience in the serotonergic...

The experts working at Bright Minds biotechnology firm are working towards the transformation of its knowledge into action and have already come up with the molecules that are capable of targeting some of the important serotonin receptors. This simply...

Bright Minds Biosciences , a biotechnology start-up, works to develop drugs that cure mental illness without any side effects. People suffering from mental disorders, addictions, impulsive disorders have to face the side effects of the medicines such...

Bright Minds Biosciences , a biotechnology company, is developing novel transformative treatments for mental illness, pain, epilepsy and neuropsychiatry. The company has several drugs that target the treatment of the mentioned illness. Most of the projects...

Bright Minds is one of the top 14 psychedelics start-ups that received record breaking funding. Though the year 2020 was difficult in many ways, it had the best conditions for psychedelics start-ups to grow. Founded in 2017, Bright Minds raised C$10 million...

Bright Minds Biosciences has a new approach to heal the brains’ issues. Mental illness is not new, but the medicines that heal it need some revolution. The biotechnology company is working on a new therapy for patients that can bring significant improvement...

The experienced neuroscientists in Bright Minds believe that a new generation of serotonergic medicines will offer a positive therapy to the patients. The patients who are not ready to take the medication because of their side effects can consume them...

Biotechnology startup, Bright Minds is developing 2nd-generation analog compounds intended to overcome these health risks. The company has assembled a stellar team of scientists who are currently working on engineering psilocybin-like compounds that are...

Psychedelic chemicals drive your mind to a new subjective state of experience, and offer you a new way of perceiving things. Though attitudes of people are shifting, psychedelics are still highly stigmatized. Despite the fact that psychedelic drugs have...